date:Sep 01, 2012
e composition was 36% curcumin, 19% demethoxycurcumin, and 43% bisdemethoxycurcumin.
One hundred overweight/ obese type-2 diabetics were randomly assigned to receive either 300 mg per day of curcuminoids or placebo for three months.
Results showed that the curcuminoid group displayed a significant decrease in blood glucose levels, hemoglobin A1C (a marker of the long-term presence of excess glucose in the blood), and insulin resistance, compared to placebo.
There was also a significant reduct